Entrada Therapeutics Ownership | Who Owns Entrada Therapeutics?


OverviewForecastRevenueFinancialsChart

Entrada Therapeutics Ownership Summary


Entrada Therapeutics is owned by 71.55% institutional investors, 12.33% insiders, and 16.12% retail investors. Baker bros. advisors lp is the largest institutional shareholder, holding 11.77% of TRDA shares. US Small-Cap Growth II Equity Comp is the top mutual fund, with 4.01% of its assets in Entrada Therapeutics shares.

TRDA Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockEntrada Therapeutics71.55%12.33%16.12%
SectorHealthcare Stocks 488.17%11.08%-399.26%
IndustryBiotech Stocks 306.59%11.10%-217.69%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Baker bros. advisors lp4.87M11.77%$32.70M
5am venture management4.41M10.85%$76.22M
Mpm asset management4.38M10.60%$29.44M
Price t rowe associates inc /md/2.90M7.15%$50.19M
Janus henderson group2.08M5.12%$36.01M
Blackrock1.69M5.06%$24.14M
Blackrock funding, inc. /de2.02M4.89%$13.59M
Vanguard group1.46M3.60%$25.32M
Fmr1.40M3.45%$24.20M
Wellington management group llp1.03M2.54%$17.84M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Mpm asset management4.38M67.92%$29.44M
5am venture management4.41M18.19%$76.22M
Stepstone group lp761.28K10.14%$5.12M
Nan fung group49.08K0.52%$329.83K
Tcg crossover management584.96K0.45%$3.93M
Baker bros. advisors lp4.87M0.32%$32.70M
Corton capital28.75K0.23%$193.23K
Virtus investment advisers11.98K0.03%$80.50K
Dynamic technology lab private24.73K0.02%$166.00K
Janus henderson group2.08M0.02%$36.01M

Top Buyers

HolderShares% AssetsChange
Janus henderson group2.08M0.02%368.91K
Vanguard group1.46M0.00%241.05K
Royce & associates lp223.25K0.02%223.25K
Blackrock1.69M0.00%207.70K
Goldman sachs group285.27K0.00%200.81K

Top Sellers

HolderShares% AssetsChange
Redmile group---560.97K
Fmr1.40M0.00%-343.58K
Price t rowe associates inc /md/2.90M0.01%-146.55K
Marshall wace, llp---100.11K
Schonfeld strategic advisors---81.41K

New Positions

HolderShares% AssetsChangeValue
Royce & associates lp223.25K0.02%223.25K$1.50M
Jacobs levy equity management134.24K0.01%134.24K$1.91M
Corton capital28.75K0.23%28.75K$193.23K
Dynamic technology lab private24.73K0.02%24.73K$166.00K
Walleye capital17.41K0.00%17.41K$116.99K

Sold Out

HolderChange
Nelson, van denburg & campbell wealth management group-4.00
Amundi-12.00
Parallel advisors-16.00
Rothschild investment-20.00
Advantage alpha capital partners lp-20.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 2025105-4.55%29,576,02637.87%712.62%6637.50%23-45.24%
Mar 31, 20251105.77%30,175,230-1.40%731.29%46-25.81%4282.61%
Dec 31, 202462-38.61%9,425,072-68.69%230.42%37-43.08%13-27.78%
Sep 30, 202410121.69%30,100,5701.46%740.98%6512.07%1863.64%
Jun 30, 2024827.89%29,668,71913.99%881.43%5861.11%11-52.17%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
US Small-Cap Growth II Equity Comp1.52M4.01%-163.10K
T. Rowe Price New Horizons1.52M4.01%-7.58K
Vanguard Total Stock Mkt Idx Inv932.09K2.45%-20.55K
iShares Russell 2000 ETF646.69K1.70%-12.29K
Fidelity Growth Compy Commingled Pl O561.18K1.51%-
T. Rowe Price New Horizons Tr-A459.17K1.21%7.79K
T. Rowe Price New Horizons Tr-Z451.38K1.20%649.00
Fidelity Growth Compy Commingled Pl S272.76K0.72%-105.17K
Vanguard Institutional Extnd Mkt Idx Tr255.86K0.67%-116.59K
Fidelity Small Cap Index250.09K0.66%-1.43K

Recent Insider Transactions


DateNameRoleActivityValue
Jul 09, 2025PARMAR KUSH Sell$52.03K
Jul 09, 2025PARMAR KUSH Sell$150.53K
Jul 09, 20255AM Ventures V, L.P.-Sell$52.03K
Jul 09, 20255AM Ventures V, L.P.-Sell$150.53K
Jul 01, 2025PARMAR KUSH Sell$132.32K

Insider Transactions Trends


DateBuySell
2025 Q3-8
2025 Q2-8
2025 Q1-1
2024 Q4-17
2024 Q3-13

TRDA Ownership FAQ


Who Owns Entrada Therapeutics?

Entrada Therapeutics shareholders are primarily institutional investors at 71.55%, followed by 12.33% insiders and 16.12% retail investors. The average institutional ownership in Entrada Therapeutics's industry, Biotech Stocks , is 306.59%, which Entrada Therapeutics falls below.

Who owns the most shares of Entrada Therapeutics?

Entrada Therapeutics’s largest shareholders are Baker bros. advisors lp (4.87M shares, 11.77%), 5am venture management (4.41M shares, 10.85%), and Mpm asset management (4.38M shares, 10.60%). Together, they hold 33.22% of Entrada Therapeutics’s total shares outstanding.

Does Blackrock own Entrada Therapeutics?

Yes, BlackRock owns 5.06% of Entrada Therapeutics, totaling 1.69M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 24.14M$. In the last quarter, BlackRock increased its holdings by 207.7K shares, a 13.98% change.

Who is Entrada Therapeutics’s biggest shareholder by percentage of total assets invested?

Mpm asset management is Entrada Therapeutics’s biggest shareholder by percentage of total assets invested, with 67.92% of its assets in 4.38M Entrada Therapeutics shares, valued at 29.44M$.

Who is the top mutual fund holder of Entrada Therapeutics shares?

US Small-Cap Growth II Equity Comp is the top mutual fund holder of Entrada Therapeutics shares, with 4.01% of its total shares outstanding invested in 1.52M Entrada Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools